Clinical Trials Directory

Trials / Completed

CompletedNCT00704457

Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

Impact Of Sacral Neuromodulation On Urine Markers For IC

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Kenneth Peters, MD · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.

Detailed description

Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.

Conditions

Timeline

Start date
2004-02-01
Primary completion
2006-12-01
Completion
2007-12-01
First posted
2008-06-25
Last updated
2013-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00704457. Inclusion in this directory is not an endorsement.

Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC) (NCT00704457) · Clinical Trials Directory